Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events.

@article{Ringleb2004BenefitOC,
  title={Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events.},
  author={P A Ringleb and Deepak L Bhatt and Alan T. Hirsch and Eric J. Topol and Werner Hacke},
  journal={Stroke},
  year={2004},
  volume={35 2},
  pages={528-32}
}
BACKGROUND AND PURPOSE The goal of this study was to examine the influence of preexisting symptomatic atherosclerotic disease on subsequent ischemic event rates and compare the efficacy of clopidogrel versus aspirin (acetylsalicylic acid, ASA) in patients with such disease. METHODS Using the CAPRIE database, we performed multivariate analyses for patients who had symptomatic atherosclerotic disease (ischemic stroke [IS] or myocardial infarction [MI]) in their medical history before enrollment… CONTINUE READING
26 Citations
13 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 13 references

M, for the CAPRIE Steering Committee. Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE

  • LA Harker, Boissel J-P, AJ Pilgrim, Gent
  • Drug Safety
  • 1999

Unifying concept of arterial vascular disease

  • GG Nenci
  • Eur Heart J. 1999;1(suppl A):A27–A30
  • 1999
3 Excerpts

Atherothrombotic events often indicate disseminated atherosclerosis: data from CAPRIE

  • S. Blecic
  • Cerebrovasc Dis. 1998;8(suppl 3):34
  • 1998

Similar Papers

Loading similar papers…